SAN RAFAEL, Calif., Aug. 1, 2019 /PRNewswire/ -- Financial Highlights (in millions of U.S. dollars, except per share data, unaudited)

SEATTLE, Aug. 1, 2019 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today reported its financial results for the second quarter and six months ended June 3

BALTIMORE, Aug. 1, 2019 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), a leading developer of clinically proven health and wellness programs, products and services, today reported strong results for the second quarter ended June 30, 2019.

BILLERICA, Mass., Aug. 1, 2019 /PRNewswire/ -- Bruker Corporation (Nasdaq: BRKR) today announced financial results for its second quarter and for the six months ended June 30, 2019.

SAN DIEGO, Aug. 1, 2019 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its financial results for the second quarter ended June 30, 2019, and provided an update on its clini

SAN DIEGO, Aug. 1, 2019 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced it will report its second quarter 2019 financial results

DENVER, Aug. 1, 2019 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced results for the quarter ended June 30, 2019.Second quarter 2019 financial highlights:Completed the sale of our DMG division to Optum. Consolidated revenues of $2,843 million. Operating income of

SAN FRANCISCO, Aug. 1, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, today announced financial results for the second quarter ended June 30, 2019 and provided updates on its programs, including positive results from a pilot efficacy study of

JAMISON, Pa., Aug. 1, 2019 /PRNewswire/ -- Physicians Endoscopy (PE) and Capital Digestive Care announce a strategic partnership in a transaction, which closed on August 1st. The companies are joining forces to offer a platform solution for gastroenterologists seeking an alternative to acquisition, allowing them to retain ownership of t

PHOENIX, Aug. 1, 2019 /PRNewswire/ -- Banner Health has appointed Peter Nakaji, MD, as Physician Executive of Neurosurgery at Banner Health and Physician Executive Director of the Banner – University Medicine Neuroscience Institute, effective August 1. He will also serve as Chair of the Department of Neur